首页> 外文期刊>Pharmacological reviews >International Union of Pharmacology. XLVI. G Protein-Coupled Receptor List.
【24h】

International Union of Pharmacology. XLVI. G Protein-Coupled Receptor List.

机译:国际药理学联合会。 XLVI。 G蛋白偶联受体列表。

获取原文
获取原文并翻译 | 示例
           

摘要

NC-IUPHAR (International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification) and its subcommittees provide authoritative reports on the nomenclature and pharmacology of G protein-coupled receptors (GPCRs) that summarize their structure, pharmacology, and roles in physiology and pathology. These reports are published in Pharmacological Reviews (http://www.iuphar.orgciuphar_arti.html) and through the International Union of Pharmacology (IUPHAR) Receptor Database web site (http://www.iuphar-db.org/iuphar-rd). The essentially complete sequencing of the human genome has allowed the cataloging of all of the human gene sequences potentially encoding GPCRs. The IUPHAR Receptor List (http://www.iuphar-db.org/iuphar-rd/list/index.htm) presents this catalog giving IUPHAR-approved nomenclature (where available), known ligands, and gene names for all of these potential receptors (excluding sensory receptors and pseudogenes) together with links to curated sequence, descriptive information, and additional links in the Entrez Gene database (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene). This list is a major new initiative of NC-IUPHAR that, through continuing curation, defines the target of our ongoing receptor classification and invites further input from the scientific community.
机译:NC-IUPHAR(国际药理学联合会术语和药物分类委员会)及其小组委员会提供了有关G蛋白偶联受体(GPCR)的命名法和药理学的权威报告,总结了它们的结构,药理作用以及在生理学和病理学中的作用。这些报告发表在《药理学评论》(http://www.iuphar.orgciuphar_arti.html)和国际药理学联合会(IUPHAR)受体数据库网站(http://www.iuphar-db.org/iuphar)上。 -rd)。人类基因组的基本完整测序已对所有可能编码GPCR的人类基因序列进行了分类。 IUPHAR受体列表(http://www.iuphar-db.org/iuphar-rd/list/index.htm)提供了此目录,其中提供了IUPHAR批准的命名法(如果有),已知的配体以及所有这些的基因名称潜在受体(不包括感觉受体和假基因),以及到Entrez基因数据库(http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=基因)。该清单是NC-IUPHAR的一项重大新举措,通过不断的策划,它定义了我们正在进行的受体分类的目标,并邀请了科学界的进一步投入。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号